Cipriani, A., Beekman, J., van der Ent, K., & Charitou, P. (2025). P098 Metabolic and excretion profiles of the FAIR therapeutics CFTR modulators nesolicaftor, posenacaftor and dirocaftor in humans (healthy volunteers). Journal of cystic fibrosis, 24, S97. https://doi.org/10.1016/j.jcf.2025.03.116
Chicago Style (17th ed.) CitationCipriani, A., J. Beekman, K. van der Ent, and P. Charitou. "P098 Metabolic and Excretion Profiles of the FAIR Therapeutics CFTR Modulators Nesolicaftor, Posenacaftor and Dirocaftor in Humans (healthy Volunteers)." Journal of Cystic Fibrosis 24 (2025): S97. https://doi.org/10.1016/j.jcf.2025.03.116.
MLA (9th ed.) CitationCipriani, A., et al. "P098 Metabolic and Excretion Profiles of the FAIR Therapeutics CFTR Modulators Nesolicaftor, Posenacaftor and Dirocaftor in Humans (healthy Volunteers)." Journal of Cystic Fibrosis, vol. 24, 2025, p. S97, https://doi.org/10.1016/j.jcf.2025.03.116.